H G van der Poel

Summary

Affiliation: University Medical Centre
Country: The Netherlands

Publications

  1. ncbi Conventional bladder wash cytology performed by four experts versus quantitative image analysis
    H G van der Poel
    Department of Urology, University Hospital, Nijmegen, The Netherlands
    Mod Pathol 10:976-82. 1997
  2. ncbi Markers for recurrence of superficial bladder cancer: what is valid?
    H G van der Poel
    Department of Urology, University Hospital Nijmegen, The Netherlands
    Curr Opin Urol 9:401-6. 1999
  3. ncbi Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival
    L S Mertens
    Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    World J Urol 31:1297-302. 2013
  4. pmc A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization
    Y Tamimi
    Department of Urology Urological Research Laboratory, University Hospital Nijmegen, The Netherlands
    Br J Cancer 74:573-8. 1996
  5. doi Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience
    R P Meijer
    Department of Urology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Postbus 90203, 1006 BE Amsterdam, The Netherlands
    Eur J Surg Oncol 39:365-71. 2013
  6. ncbi Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer
    J A Witjes
    Department of Urology, University Hospital Nijmegen, The Netherlands
    Eur Urol 33:387-91. 1998
  7. doi Short-term outcome after cystectomy: comparison of two different perioperative protocols
    R R de Vries
    Department of Urology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Urol Int 88:383-9. 2012
  8. ncbi Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis
    H G van der Poel
    Department of Urology, University Hospital Nijmegen, Rotterdam, The
    Eur Urol 35:197-203. 1999
  9. ncbi Can biological markers replace cystoscopy? An update
    H G van der Poel
    Department of Urology, Antoni van Leeuwenhoek Hospital NKI, Amsterdam, The Netherlands
    Curr Opin Urol 11:503-9. 2001
  10. ncbi The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer
    D H Schamhart
    Department of Urology, University of Amsterdam, Nijmegen, The Netherlands
    Eur Urol 34:99-106. 1998

Collaborators

Detail Information

Publications20

  1. ncbi Conventional bladder wash cytology performed by four experts versus quantitative image analysis
    H G van der Poel
    Department of Urology, University Hospital, Nijmegen, The Netherlands
    Mod Pathol 10:976-82. 1997
    ..Image analysis was superior to cytologic analysis for the prediction of tumor recurrence after normal findings at cystoscopic examination...
  2. ncbi Markers for recurrence of superficial bladder cancer: what is valid?
    H G van der Poel
    Department of Urology, University Hospital Nijmegen, The Netherlands
    Curr Opin Urol 9:401-6. 1999
    ..Clinical markers remain the most practical in decision-making and can identify high-risk patients. Molecular markers may be useful, but as yet insufficient evidence exists on their efficacy for daily use...
  3. ncbi Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival
    L S Mertens
    Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    World J Urol 31:1297-302. 2013
    ..To analyse whether the reported differences in nodal yield at pelvic lymph node dissection (PLND) for bladder cancer, between two hospitals, are reflected in the survival rates...
  4. pmc A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization
    Y Tamimi
    Department of Urology Urological Research Laboratory, University Hospital Nijmegen, The Netherlands
    Br J Cancer 74:573-8. 1996
    ..High HMG-I(Y) levels measured by RISH were indicative of a worse prognosis, albeit that additional value over the more subjective grading methods was not evident...
  5. doi Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience
    R P Meijer
    Department of Urology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Postbus 90203, 1006 BE Amsterdam, The Netherlands
    Eur J Surg Oncol 39:365-71. 2013
    ..To evaluate the outcome of patients with locally advanced muscle-invasive and/or lymph node positive bladder cancer treated with induction chemotherapy and additional surgery...
  6. ncbi Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer
    J A Witjes
    Department of Urology, University Hospital Nijmegen, The Netherlands
    Eur Urol 33:387-91. 1998
    ..To study the value of two outpatient urine tests with regard to the diagnosis and recurrence of bladder tumors...
  7. doi Short-term outcome after cystectomy: comparison of two different perioperative protocols
    R R de Vries
    Department of Urology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Urol Int 88:383-9. 2012
    ..To compare the outcome of two perioperative protocols with respect to postoperative management of cystectomy patients. Patients and..
  8. ncbi Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis
    H G van der Poel
    Department of Urology, University Hospital Nijmegen, Rotterdam, The
    Eur Urol 35:197-203. 1999
    ..This retrospective analysis may help in the management of future cases. Due to the retrospective nature of the data, no comparison between surgical and nonsurgical management is possible...
  9. ncbi Can biological markers replace cystoscopy? An update
    H G van der Poel
    Department of Urology, Antoni van Leeuwenhoek Hospital NKI, Amsterdam, The Netherlands
    Curr Opin Urol 11:503-9. 2001
    ..The data from retrospective analyses are insufficient to justify clinical integration, and the need to replace cystoscopy with these novel assays remains to be proven...
  10. ncbi The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer
    D H Schamhart
    Department of Urology, University of Amsterdam, Nijmegen, The Netherlands
    Eur Urol 34:99-106. 1998
    ..In this study, the mode of action, sensitivity and specificity of the Bard(R) BTA test, detecting a tumor-associated release of a basement membrane complex, was addressed and compared with voided urine cytology (VUC)...
  11. doi Sequential treatment for recurrent localized prostate cancer
    H G van der Poel
    Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Surg Oncol 97:377-82. 2008
    ..Genitourinary functions were better preserved in the salvage radiotherapy group compared to the salvage prostatectomy group...
  12. doi Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes
    R P Meijer
    Department of Urology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    J Urol 187:446-50. 2012
    ..Surgery at each hospital was done by the same 4 staff urologists using a standardized extended bilateral pelvic lymph node dissection template...
  13. ncbi Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study
    F C d'Ancona
    Department of Urology, University Hospital Nijmegen, The Netherlands
    Prostate 40:28-36. 1999
    ..In this study we analyzed histological parameters (vessel density and epithelium-stroma (E/S) ratio) in patients who were selected for high-energy TUMT and related these parameters to clinical outcome...
  14. ncbi Robot assisted laparoscopic prostatectomy: initial tips and tricks
    H G van der Poel
    Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Minerva Urol Nefrol 61:351-62. 2009
    ..These properties render robot procedures appealing for the now-a-days more and more image-guided approach to surgery...
  15. ncbi Molecular markers in the diagnosis of prostate cancer
    H G van der Poel
    Department of Urology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Crit Rev Oncol Hematol 61:104-39. 2007
    ..The further understanding of interaction of inflammation, diet, and genetic predisposition will improve risk stratification in the near future...
  16. ncbi Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer
    J P Sedelaar
    Department of Urology, University Medical Center, Nijmegen, The Netherlands
    Eur Urol 40:285-93. 2001
    ..The aim of the present study was to correlate three-dimensional contrast-enhanced power Doppler ultrasound (3D-CE-PDU) findings with MVD characteristics of radical prostatectomy specimens...
  17. ncbi New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration
    A J M Mol
    Department of Urology, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands
    J Cancer Res Clin Oncol 133:687-95. 2007
    ..Analyzing a combination of the potential markers discussed in this review is expected to be a better approach toward discriminating high- from low-risk tumors in an early stage of prostate cancer...
  18. ncbi Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer
    H G van der Poel
    Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Urol Int 77:50-6. 2006
    ....
  19. ncbi Bladder cancer in women
    H G van der Poel
    University Hospital, Nijmegen, The Netherlands
    Int Urogynecol J Pelvic Floor Dysfunct 10:207-12. 1999
    ..The treatment of superficial bladder cancer tumors is similar for men and women. In recent years orthotopic bladder replacement has improved quality of life after cystectomy in invasive disease...
  20. ncbi Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors
    J R Spermon
    Department of Urology, University Medical Center Nijmegen, Nijmegen, The Netherlands
    Urology 59:923-9. 2002
    ....